New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 27, 2012
12:19 EDTBAYRY, DECK, WCRX, MDRX, JAZZ, CVH, CERN, SBUX, CVX, SIMO, CRAY, F, PG, MXWL, EXPE, MRK, AMZNOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday, in spite of Spain's ratings being cut by S&P and a U.S. GDP reading that disappointed. Each of the major indices is higher, with the Nasdaq the leader. The averages have moved in a narrow range since the open as market participants digest all the earnings and economic news that was delivered this week. Earnings have come in better than expected, which has led the averages to rebound and stand ready for a positive close for the week. The economic data remains mixed, as housing and labor continue to limp along but consumer confidence is showing an uptick. For now earnings have trumped macro data, leading to a move higher for equities... ECONOMIC EVENTS: In the U.S., gross domestic product reportedly grew at an annual rate of 2.2% in the first quarter, versus an expected increase of 2.5%. Personal consumption increased 2.9%, versus expectations for an increase of 2.3%. The University of Michigan Consumer Confidence report had a reading of 76.4, versus the expected 75.7. Regarding Europe, S&P cut its credit rating on Spain to BBB+ from A and said its long-term outlook is negative... COMPANY NEWS: Amazon.com (AMZN), Ford (F) and Starbucks (SBUX) all exceeded expectations on the top and bottom lines, but only Amazon was rewarded by investors. Shares of the internet giant advanced more than 14% on the heels of upgrades from Goldman, Merrill Lynch, Nomura and Sun Trust on its strong results... The three Dow components reporting earnings, Chevron (CVX), Merck (MRK) and Procter & Gamble (PG), all declined in spite of the fact that each beat consensus earnings expectations. P&G was the Dow's worst performer, sliding 3.5%, after lowering its outlook for next quarter... Among the many other companies reporting earnings, advancers included Expedia (EXPE), Cray (CRAY) and Cerner (CERN); decliners included Maxwell (MXWL), Silicon Motion (SIMO) and Coventry Health (CVH)... MAJOR MOVERS: Among the notable gainers were Jazz Pharmaceuticals (JAZZ), up over 15%, after announcing plans to acquire EUSA Pharma for $650M, and Warner Chilcott (WCRX), up 9%, after the Times of London said that Bayer (BAYRY) may offer $32 per share for the company. Noteworthy losers included Allscripts (MDRX), down 41%, following downgrades by at least eight firms after its earnings and guidance severely missed consensus and the company reported the ouster of its board chairman, three other board members and its CFO, and Deckers Outdoor (DECK), down more than 25%, after lowering its full year sales and profit outlook... INDICES: Near noon, the Dow was up 30.92, or 0.23%, to 13,235.54; the Nasdaq was up 14.12, or 0.46%, to 3,064.73; and the S&P 500 was up 2.31, or 0.17%, to 1,402.29.
News For AMZN;PG;CVX;MRK;F;SBUX;EXPE;CRAY;CERN;MXWL;SIMO;CVH;JAZZ;WCRX;BAYRY;MDRX;DECK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 >>
January 29, 2016
08:53 EDTAMZNAmazon.com shares should be bought on weakness, says JMP Securities
Subscribe for More Information
08:44 EDTCVXChevron falls after earnings
Subscribe for More Information
08:42 EDTCVXChevron reports 2015 capital and exploratory expenditures drop to $34B
Subscribe for More Information
08:41 EDTCVXChevron reports Q4 U.S. refinery crude oil input down 1%
Subscribe for More Information
08:39 EDTCVXChevron International upstream operations earned $593M in Q4
Subscribe for More Information
08:38 EDTCVXChevron reports Q4 net oil-equivalent production 2.67M boepd
Worldwide net oil-equivalent production was 2.67M barrels per day in fourth quarter 2015, up from 2.58M barrels per day in the 2014 fourth quarter. U.S. upstream operations incurred a loss of $1.95B in fourth quarter 2015 compared to earnings of $432M from a year earlier. The decrease was due to lower crude oil realizations, higher depreciation expenses, higher exploration expenses and lower gains on asset sales, partially offset by higher crude oil production. The increase in depreciation and exploration expenses was primarily due to impairments and project cancellations. The company's average sales price per barrel of crude oil and natural gas liquids was $35 in fourth quarter 2015, down from $66 a year ago. The average sales price of natural gas was $1.54 per thousand cubic feet, compared with $3.34 in last year's fourth quarter.
08:35 EDTCVXChevron added about 1.02B barrels of net oil-equivalent proved reserves in 2015
Chevron said that the company added approximately 1.02 billion barrels of net oil-equivalent proved reserves in 2015. These additions, which are subject to final reviews, equate to approximately 107 percent of net oil-equivalent production for the year. The largest additions were from production entitlement effects in several locations and drilling results for the Permian Basin in the United States and the Wheatstone Project in Australia. At year-end, balances of cash, cash equivalents, time deposits and marketable securities totaled $11.3B, a decrease of $1.9B from the end of 2014. Total debt at December 31, 2015 stood at $38.6B, an increase of $10.8B from a year earlier.
08:33 EDTCVXChevron Q4 earnings include impairments and other charges of $1.1B
"Our 2015 earnings were down significantly from the previous year, reflecting a nearly 50% year-on-year decline in crude oil prices. We're taking significant action to improve earnings and cash flow in this low price environment. Operating expenses and capital spending were reduced $9B in 2015 from 2014, and I expect similarly large reductions again in 2016. In addition, asset sales proceeds were $6B in 2015, with additional sales planned for 2016 and 2017," said Chairman and CEO John Watson.
08:33 EDTAMZNAmazon.com weakness creates buying opportunity, says RBC Capital
Subscribe for More Information
08:32 EDTCVXChevron reports Q4 EPS with impariments and charges (31c), consensus 46c
Subscribe for More Information
07:38 EDTDECKDeckers Outdoor is a top recovery pick, says Canaccord
Subscribe for More Information
07:36 EDTCVXAnalysts still predicting mergers as oil slump drags on, WSJ reports
Bankers and analysts have been predicting a wave of merger activity will come almost since crude prices began to fall from over $100 a barrel, but the only big acquisition by an oil major so far has been Shell's (RDS.A) purchase of BG Group (BRGYY), said The Wall Street Journal, which added that analysts still believe deal-making is likely to return this year if prices continue to languish. With Chevron (CVX) set to report today and its big peers soon to follow, analysts are expecting the four biggest publicly traded Western oil companies to have their weakest combined profits since 1998, the Journal noted. The report noted that U.S. shale oil producers, such as Apache (APA) and Whiting Petroleum (WLL), were previously targeted though potential sellers were reluctant to accept offers as they hoped for a rebound in oil prices and potential buyers wondered if any deal struck would look expensive if crude prices fell further, but "both impediments are gone now," the Journal contends. Reference Link
07:35 EDTAMZNJPMorgan ups Amazon target, says buy on the weakness
JPMorgan analyst Doug Anmuth admits that after four quarters of "big beats and clean results," Amazon.com's Q4 results last night were more mixed. The analyst, however, believes Amazon's "strong topline growth trajectory" in unchanged. He expects the company's margin expansion to continue. Anmuth raised his price target for the shares to $825 from $800 and reiterates an Overweight rating on the name. He recommends buying Amazon on today's selloff. The stock is down $62.35 to $573.00 in pre-market trading.
07:24 EDTAMZNAmazon.com outlook remains positive, says Oppenheimer
After Amazon.com reported lower than expected North American margins and the stock fell in after-hours trading, Oppenheimer blames the miss on seasonal Q4 factors. Consequentially, the firm does not expect a repeat performance this quarter. It says that pricing remains strong at AWS, and it remains upbeat on the company's outlook. Oppenheimer cut its price target on the name to $700 from $745 but keeps an Outperform rating on the shares.
06:55 EDTJAZZ2016 could be pivotal year for Jazz, says Deutsche Bank
Deutsche Bank analyst Gregg Gilbert says 2016 could be a pivotal year for Jazz Pharmaceuticals. The analyst sees several potential catalysts for the shares, including potentially greater certainty on Xyrem duration via a patent settlement or a win in court, FDA approval of defibrotide and acquisitions supported by the company's under-leveraged balance sheet. Gilbert keeps a Buy rating on Jazz with a $167 price target.
06:50 EDTAMZNDeutsche says buy Amazon 'once the dust settles'
Deutsche Bank analyst Ross Sandler says the post-earnings pullback in shares of Amazon.com shares should create a "nice buying opportunity once the dust settles." He calls around $530 per share a "decent entry point" and notes the Q4 results did not change his long-term bullish thesis. Ross keeps a Buy rating on Amazon with an $800 price target.
06:40 EDTAMZNAmazon.com results better than selloff suggested, says Citi
Citi analyst Mark May says Amazon.com's Q4 results are better than the after-hours stock selloff suggested. May continues to see the business trending toward $20 per share in adjusted earnings per share in 2018. He lowered his price target for the stock to $780 from $785 and reiterates a Buy rating on Amazon.
06:29 EDTAMZNOptions expected to be active: AMZN EA MSFT EWJ FLEX SWKS GOOG GOOGL FB
Subscribe for More Information
05:49 EDTAMZNAmazon.com selloff a buying opportunity, says Piper Jaffray
Subscribe for More Information
05:33 EDTMRKStocks with implied volatility movement; VRX MRK
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use